Varicella

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 6 No 10
Volume 6
Issue 10

One week after vaccination with diphtheria, tetanus, and acellular pertussis/inactivated poliovirus/hepatitis B, Haemophilus influenzae type b, pneumococcal conjugate, and rotavirus, this 2Z\x-month-old infant presented with a vesicular rash. No other children in the home had a rash. The infant's primary caregiver was the grandmother, who had shingles 2 weeks earlier.

One week after vaccination with diphtheria, tetanus, and acellular pertussis/inactivated poliovirus/hepatitis B, Haemophilus influenzae type b, pneumococcal conjugate, and rotavirus, this 2Z\x-month-old infant presented with a vesicular rash. No other children in the home had a rash. The infant's primary caregiver was the grandmother, who had shingles 2 weeks earlier.

Varicella-zoster virus, a herpes virus, causes 2 distinct clinical diseases: varicella (chickenpox) and herpes zoster (shingles). Adults with shingles can infect susceptible children via contact with vesicular fluid, which contains an enormous load of virus particles. In infants, varicella usually has a benign course and does not require treatment.

Because this infant had chickenpox, vaccination after his first birthday may not be required. Consultation with a local infectious disease specialist may provide further clarification.

Treatment of a newborn with varicella-zoster immunoglobulin may be required if a rash develops in the mother within 5 days before or 2 days after childbirth. If varicella lesions subsequently develop in the infant, acyclovir should be administered promptly.1,2 *

References:

REFERENCES:

1.

Sauerbrei A, Wutzler P. Neonatal varicella.

J Perinatol.

2001;21:545-549.

2.

American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds.

Red Book: 2006 Report of the Committee on Infectious Diseases.

27th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2006:711-725.

Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.